Albany International (AIN) to pay $0.18 on Jul 8, 2019; Avrobio (AVRO) Shorts Increased By 16.63%

Albany International Corp. (NYSE:AIN) Logo

Avrobio Inc (NASDAQ:AVRO) had an increase of 16.63% in short interest. AVRO’s SI was 694,300 shares in May as released by FINRA. Its up 16.63% from 595,300 shares previously. With 269,300 avg volume, 3 days are for Avrobio Inc (NASDAQ:AVRO)’s short sellers to cover AVRO’s short positions. The SI to Avrobio Inc’s float is 6.76%. The stock decreased 2.46% or $0.37 during the last trading session, reaching $14.67. About 90,110 shares traded. AVROBIO, Inc. (NASDAQ:AVRO) has 0.00% since May 31, 2018 and is . It has underperformed by 4.37% the S&P500.

Albany International Corp (NYSE:AIN) is expected to pay $0.18 on Jul 8, 2019. (NYSE:AIN) shareholders before Jun 6, 2019 will receive the $0.18 dividend. Albany International Corp’s current price of $69.57 translates into 0.26% yield. Albany International Corp’s dividend has Jun 7, 2019 as record date. May 10, 2019 is the announcement. The stock decreased 1.11% or $0.78 during the last trading session, reaching $69.57. About 298,710 shares traded or 89.73% up from the average. Albany International Corp. (NYSE:AIN) has risen 22.90% since May 31, 2018 and is uptrending. It has outperformed by 18.53% the S&P500. Some Historical AIN News: 07/05/2018 - ALBANY INTERNATIONAL 1Q ADJ EPS 54C, EST. 51C; 30/04/2018 - Research Report Identifies Albany International, JBG SMITH Properties, Preferred Apartment Communities, National Western Life G; 07/05/2018 - ALBANY INTERNATIONAL CORP - OUTLOOK FOR MC & AEC IN 2018 IS UNCHANGED; 07/05/2018 - ALBANY INTERNATIONAL CORP AIN.N SEES FY 2020 SALES $475 MLN TO $550 MLN; 07/05/2018 - ALBANY INTERNATIONAL CORP - BEYOND 2018, REMAIN ON TRACK TOWARD GOAL OF 18% TO 20% ADJUSTED EBITDA AS A PERCENTAGE OF SALES IN 2020; 11/05/2018 - Albany International Declares Dividend; 12/04/2018 - Albany International Announces Earnings Release Date; 17/04/2018 - Albany International Closes Above 50-Day Moving Average; 19/04/2018 - DJ Albany International Corp Class A, Inst Holders, 1Q 2018 (AIN); 07/05/2018 - Albany International 1Q EPS 32c

More notable recent AVROBIO, Inc. (NASDAQ:AVRO) news were published by: Finance.Yahoo.com which released: “Here’s What Hedge Funds Think About AVROBIO, Inc. (AVRO) - Yahoo Finance” on May 12, 2019, also Benzinga.com with their article: “95 Biggest Movers From Yesterday - Benzinga” published on May 09, 2019, Businesswire.com published: “AVROBIO, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update - Business Wire” on May 13, 2019. More interesting news about AVROBIO, Inc. (NASDAQ:AVRO) were released by: Business.Financialpost.com and their article: “Repare Therapeutics Appoints Dr. Maria Koehler as Chief Medical Officer, Katina Dorton as Chief Financial Officer and Carol Schafer to its Board of Directors - Financial Post” published on May 01, 2019 as well as Streetinsider.com‘s news article titled: “Form 8-K AVROBIO, Inc. For: May 13 - StreetInsider.com” with publication date: May 13, 2019.

AVROBIO, Inc., a clinical stage gene therapy company, focuses on developing ex vivo lentiviral gene therapies to treat rare diseases following a single dose. The company has market cap of $352.41 million. The company's gene therapies employ hematopoietic stem cells that are extracted from the patient and modified with lentiviral vectors to insert a functional copy of the gene that is defective in the target disease. It currently has negative earnings. The Company’s lead product candidate is AVR-RD-01, which is in ongoing Phase II clinical trial and investigator-sponsored Phase I clinical trial for the treatment of fabry disease.

Investors sentiment increased to 1.38 in 2018 Q4. Its up 0.24, from 1.14 in 2018Q3. It increased, as 16 investors sold Albany International Corp. shares while 64 reduced holdings. 23 funds opened positions while 68 raised stakes. 27.86 million shares or 1.50% more from 27.45 million shares in 2018Q3 were reported. Citadel Advsrs Ltd reported 24,042 shares. Moreover, Gamco Invsts Et Al has 0.03% invested in Albany International Corp. (NYSE:AIN) for 53,063 shares. Blackrock owns 4.12M shares. First Tru Advsrs Limited Partnership holds 0.01% or 54,163 shares in its portfolio. Comerica Fincl Bank holds 29,768 shares. Earnest Partners Ltd Liability Company accumulated 1.42M shares. Cramer Rosenthal Mcglynn Ltd Liability reported 276,699 shares. Gsa Cap Prns Limited Liability Partnership invested 0.03% in Albany International Corp. (NYSE:AIN). Cwm Ltd Liability Corp owns 6 shares or 0% of their US portfolio. Mason Street Advsrs Limited Liability Com holds 9,006 shares or 0.01% of its portfolio. Moreover, Regions Corporation has 0% invested in Albany International Corp. (NYSE:AIN). Los Angeles Cap Mgmt & Equity holds 55,828 shares or 0.02% of its portfolio. Moreover, Hsbc Holding Public Ltd Liability Company has 0% invested in Albany International Corp. (NYSE:AIN) for 3,475 shares. Captrust Advsrs reported 0% in Albany International Corp. (NYSE:AIN). Marshall Wace Ltd Liability Partnership invested in 0% or 2,049 shares.

Albany International Corp. engages in textile and materials processing businesses worldwide. The company has market cap of $2.25 billion. The firm operates through Machine Clothing and Albany Engineered Composites (AEC) divisions. It has a 21.55 P/E ratio. The MC segment designs, makes, and markets paper machine clothing.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.